STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM) Institutional Ownership

CUSIP: 86323X106

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
STRM on Nasdaq
Shares outstanding
4,279,000
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 86323X106?
CUSIP 86323X106 identifies STRM - STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tamarack Advisers, LP 3.6% $35,430 154,044 Ferayorni Justin John 13 Nov 2024

Institutional Holders of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$1,038,000 0
2025 Q2 200,000 $1,038,000 +$1,038,000 $5.19 1
2025 Q1 0 $0 -$230 0
2024 Q4 0 $0 -$2,015,639 0
2024 Q3 8,760,612 $2,015,639 -$1,722,043 $0.23 23
2024 Q2 12,386,588 $5,719,610 +$4,130 $0.46 29
2024 Q1 12,286,476 $5,898,517 -$196,296 $0.48 28
2023 Q4 17,743,035 $7,561,600 -$349,112 $0.42 39
2023 Q3 17,883,693 $17,266,568 -$1,226,521 $0.97 43
2023 Q2 19,143,429 $24,292,810 +$148,873 $1.27 39
2023 Q1 18,942,356 $34,066,810 +$1,806,661 $1.80 37
2022 Q4 17,944,848 $28,343,327 +$2,613,366 $1.58 37
2022 Q3 16,375,130 $19,466,900 +$5,714,521 $1.19 29
2022 Q2 11,568,957 $14,685,700 -$202,813 $1.27 24
2022 Q1 11,703,066 $18,724,000 -$7,236,951 $1.60 27
2021 Q4 16,598,901 $24,686,000 -$1,330,145 $1.47 26
2021 Q3 17,411,227 $30,465,500 -$1,748,772 $1.75 29
2021 Q2 18,406,782 $32,568,700 -$1,261,446 $1.77 32
2021 Q1 18,962,602 $38,835,500 +$11,453,580 $2.05 33
2020 Q4 14,051,323 $22,135,600 +$423,040 $1.56 29
2020 Q3 13,865,990 $21,632,600 +$203,880 $1.56 27
2020 Q2 13,312,215 $17,706,566 +$580,695 $1.33 25
2020 Q1 13,333,474 $11,331,670 -$1,105,824 $0.85 27
2019 Q4 14,133,488 $19,646,178 +$7,212,586 $1.39 26
2019 Q3 8,973,869 $9,745,220 +$159,990 $1.08 27
2019 Q2 8,810,068 $13,411,402 -$28,814 $1.51 28
2019 Q1 8,868,209 $9,310,710 -$59,108 $1.05 27
2018 Q4 8,976,228 $7,231,825 -$255,045 $0.81 30
2018 Q3 7,427,930 $8,808,036 -$117,859 $1.18 32
2018 Q2 7,522,393 $10,738,994 -$72,827 $1.41 28
2018 Q1 7,603,017 $13,973,368 +$700,806 $1.84 29
2017 Q4 7,195,641 $12,132,000 -$8,314 $1.69 32
2017 Q3 7,139,913 $10,495,000 -$449,962 $1.47 23
2017 Q2 7,573,831 $8,103,000 -$1,541,363 $1.07 27
2017 Q1 9,111,200 $9,292,000 +$298,970 $1.02 33
2016 Q4 9,185,228 $11,463,000 +$335,140 $1.25 35
2016 Q3 9,028,616 $16,568,000 +$857,780 $1.84 39
2016 Q2 8,565,111 $10,278,000 -$1,058,889 $1.20 35
2016 Q1 9,192,354 $12,962,000 -$383,602 $1.41 35
2015 Q4 9,568,204 $13,484,000 -$6,326,341 $1.41 33
2015 Q3 11,091,123 $25,398,000 -$364,151 $2.29 37
2015 Q2 11,193,300 $31,337,892 -$492,974 $2.80 37
2015 Q1 11,273,029 $40,083,000 -$1,116,357 $3.55 34
2014 Q4 11,261,126 $48,748,211 -$507,490 $4.33 39
2014 Q3 11,076,842 $51,283,000 -$202,093 $4.63 39
2014 Q2 11,092,105 $53,507,000 +$3,797,425 $4.80 40
2014 Q1 10,342,660 $52,027,000 +$1,099,164 $5.03 39